Matches in Nanopublications for { ?s ?p "[COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP124045.RAYn1WBRpyHz36-QraKKMcoaahVw82byq9hwyEzIasAb0130_assertion description "[COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP124045.RAYn1WBRpyHz36-QraKKMcoaahVw82byq9hwyEzIasAb0130_provenance.
- NP123995.RAlDGybAMcVKSZSfMFAe7Tqs3N7D6pKCNzvtvkYC5CfFs130_assertion description "[COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123995.RAlDGybAMcVKSZSfMFAe7Tqs3N7D6pKCNzvtvkYC5CfFs130_provenance.
- NP124120.RAolXzDNxKBaCU610RUzoQsBDm1Go3NcsGtLhVks0r1Mo130_assertion description "[COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP124120.RAolXzDNxKBaCU610RUzoQsBDm1Go3NcsGtLhVks0r1Mo130_provenance.
- NP187180.RA3K90B7vyi3guuboE3O2JxDGLaOevGSqxYSRLkDsvgV4130_assertion description "[COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187180.RA3K90B7vyi3guuboE3O2JxDGLaOevGSqxYSRLkDsvgV4130_provenance.
- NP187305.RA7QTFbwq4HcvPgeFQ4hxuzZVam1zdMCDaOcz5jkyVDkI130_assertion description "[COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187305.RA7QTFbwq4HcvPgeFQ4hxuzZVam1zdMCDaOcz5jkyVDkI130_provenance.
- assertion description "[COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP187230.RAtkca5s344hgd8d_IRsMx9dRAyq1osAZdUmV28bEBYCA130_assertion description "[COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187230.RAtkca5s344hgd8d_IRsMx9dRAyq1osAZdUmV28bEBYCA130_provenance.
- NP227088.RAN6l__aVjTvBNWAYoEr3BhBSrzrBenST8JlPJkQNyoi8130_assertion description "[COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227088.RAN6l__aVjTvBNWAYoEr3BhBSrzrBenST8JlPJkQNyoi8130_provenance.
- NP227089.RANeXFXeFYsAS9OQpqO0fKcKBNQeLvrwZsTRPYBNpKhA0130_assertion description "[COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227089.RANeXFXeFYsAS9OQpqO0fKcKBNQeLvrwZsTRPYBNpKhA0130_provenance.
- NP227090.RAiQ9MLYxgvZ4CRO2MFk16muZgBZJwSbU--fCerOiln9s130_assertion description "[COX-2, MMP-2 and MMP-9 were expressed in a high percentage of primary endometrial carcinomas and their expressions may be associated closely with parameters of tumor aggressiveness.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227090.RAiQ9MLYxgvZ4CRO2MFk16muZgBZJwSbU--fCerOiln9s130_provenance.